Idenix to Host Conference Call Discussing Fourth Quarter and Year End 2009 Financial Results
February 11 2010 - 3:05PM
PR Newswire (US)
CAMBRIDGE, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc., (NASDAQ:IDIX) announced today that it will
report its financial results for the fourth quarter and year end
2009 on Thursday, February 25, 2010 after U.S. financial markets
close. In conjunction with the issuance of the press release,
Idenix management will host a conference call at 4:30 p.m. ET on
Thursday, February 25, 2010 to discuss the company's financial
results for the fourth quarter of 2009 and provide an update on the
company's development programs. To access the call please dial
800-471-3635 U.S./Canada or 706-758-9475 International and enter
passcode 54113451 or to listen to a live webcast go to "Calendar of
Events" in the Idenix Investor Center at http://www.idenix.com/. A
replay of the call will also be available from February 25, 2010,
6:30 p.m. ET until March 11, 2010, 11:59 p.m. ET. To access the
replay, please dial 800-642-1687 U.S./Canada or 706-645-9291
International and enter passcode 54113451. An archived webcast will
also be available for two weeks after the call on the Idenix
website. About Idenix Idenix Pharmaceuticals, Inc., headquartered
in Cambridge, Massachusetts, is a biopharmaceutical company engaged
in the discovery and development of drugs for the treatment of
human viral diseases. Idenix's current focus is on the treatment of
infections caused by the hepatitis C virus. For further information
about Idenix, please refer to http://www.idenix.com/. Contact: Teri
Dahlman (617)-995-9905 DATASOURCE: Idenix Pharmaceuticals, Inc.
CONTACT: Teri Dahlman of Idenix Pharmaceuticals, Inc.,
+1-617-995-9905 Web Site: http://www.idenix.com/
Copyright